Tirzepatide — Tirze-Pep 10mg by Dragon Pharma
Tirze-Pep 10mg is Dragon Pharma's high-concentration formulation of Tirzepatide — the same dual GLP-1/GIP receptor agonist as the standard Tirze-Pep vial, supplied at double the concentration for users on advanced maintenance protocols. A single 10mg vial covers a wider dosing range without requiring multiple smaller vials, making it more practical for users who have titrated up to higher weekly doses.
Also searched as: Tirzepatide 10mg, Tirze-Pep 10mg vial, high-dose tirzepatide, GLP-1 GIP 10mg peptide.
What Is Tirzepatide 10mg?
Tirzepatide is a synthetic peptide activating both GLP-1 and GIP receptors — a dual mechanism that slows gastric emptying, increases satiety and improves insulin sensitivity. The 10mg vial contains the identical active substance as the 5mg version, simply at double the concentration. This does not change the compound's mechanism or effects at a given dose — it changes how much total Tirzepatide is available per vial, which is relevant for users on higher maintenance doses who would otherwise need to use multiple 5mg vials.
Effects and Benefits
- Significant appetite reduction supporting substantial reductions in food intake
- Slowed gastric emptying contributing to prolonged satiety after meals
- Improved insulin sensitivity and glucose regulation
- Higher per-vial concentration reduces the number of vials needed for advanced maintenance protocols
- No suppression of natural testosterone — does not require Post Cycle Therapy
Dosage and Administration
| Phase | Typical Dose | Notes |
|---|---|---|
| Standard maintenance | 5 mg/week | Half the 10mg vial per dose |
| Advanced maintenance | 7.5 mg/week | Three-quarters of the 10mg vial |
| High-dose maintenance | 10 mg/week | Full vial content per dose |
Tirzepatide remains dosed once weekly via subcutaneous injection regardless of vial strength. The 10mg vial is intended for users who have already titrated upward through the standard schedule (typically starting at 2.5mg and increasing every 4 weeks) and are now maintaining at 7.5mg/week or above. Users beginning Tirzepatide for the first time should generally start with the 5mg Tirze-Pep vial, as the initial titration doses are well below this concentration.
Side Effects
Side effects are identical in nature to the 5mg formulation, as the active substance and mechanism are the same:
- Nausea, particularly during dose increases — typically subsides as the body adjusts
- Reduced appetite can, if excessive, lead to inadequate caloric or protein intake — monitoring intake remains important
- Constipation or diarrhoea in some users, related to slowed gastric emptying
- Injection site reactions are possible but generally mild
- No impact on testosterone, estrogen or the HPG axis — does not require PCT
Tirze-Pep 10mg vs Tirze-Pep 5mg
Dragon Pharma offers Tirzepatide in two vial strengths:
- Tirze-Pep 10mg vial — for advanced maintenance doses (7.5-10mg/week), reducing the number of vials needed
- Tirze-Pep 5mg vial — the standard starting point, suited to the titration schedule and standard maintenance doses (2.5-5mg/week)
New users should start with the 5mg vial and titrate gradually. The 10mg vial becomes more cost-effective once a user has reached maintenance doses of 7.5mg/week or higher, where a single 5mg vial would no longer cover a full dose.
Reconstitution and Storage
Tirze-Pep 10mg is supplied as a lyophilised powder requiring reconstitution with bacteriostatic water before use. Because the vial contains a higher total peptide content, the reconstitution volume chosen determines the concentration per unit drawn — use a peptide calculator or dosing guide to determine the correct reconstitution volume for your intended dose. Add bacteriostatic water slowly along the vial wall and swirl gently — do not shake. Store the reconstituted vial refrigerated at 2-8°C and never freeze.
"Tirze-Pep 10mg is formulated to the same high-purity standard as our 5mg vial, simply concentrated for users on advanced maintenance protocols who need more Tirzepatide per vial."
Stacking and Related Compounds
Tirzepatide is often used independently, but some protocols combine it with:
- Cagrilintide for an amylin-agonist addition to appetite regulation
- AOD-9604 for users targeting fat metabolism alongside appetite control
- MOTS-c for metabolic and mitochondrial support